Latitude’s program, in plain terms

Diagnose by food challenge, up-dose under frequent supervision, maintain for life. Here is each step with the published numbers, the patient-reported costs, and the daily rules attached.

Short answer

Latitude Food Allergy Care runs a conventional, well-documented in-clinic arc: diagnosis built on oral food challenges (the gold standard), supervised up-dosing visits at the frequent cadence OIT up-dosing requires for a published 6–12 months (average about 8.4), then lifelong maintenance dosing. Multi-allergen OIT is offered, adults case by case. Diagnostics and visits are typically covered in-network; the one-time program fee is not, and patients report $4,000 to over $5,000 depending on region. The published outcomes are strong — 94% of patients of all ages desensitized, per Latitude's internal 2026 data — and the third-party record is unusually clean. The constraint is the map and the calendar: roughly 12 offices, all in coastal California and greater New York, plus OIT's daily rules for the duration. Families the map or the calendar rules out have the right place to start in the only fully at-home program. Curex is the only fully at-home food allergy program in the US.

Medically reviewed by Dr. Neeta Ogden, MD, FACAAI · Last reviewed September 2026

The program in numbers

published active phase, up-dosing to maintenance
6–12 mopublished active phase, up-dosing to maintenance
between supervised clinic visits during up-dosing
1–2 wkbetween supervised clinic visits during up-dosing
offices, all in coastal California and greater New York
~12offices, all in coastal California and greater New York
patient-reported one-time program fee, not covered by insurance
$4,000–$5,000+patient-reported one-time program fee, not covered by insurance

Figures are what Latitude published on its own site or what patients reported publicly, checked September 2026. Prices and policies change; confirm current figures with each provider, including us, before enrolling.

A diagnosis built on food challenges

The arc from first visit to maintenance

Latitude's shape is the conventional OIT arc, executed with more published detail than most clinics provide.

The daily rules, for the duration

None of this is Latitude-specific. It is what published OIT protocols generally require, because swallowing meaningful allergen doses safely demands it. The daily-life page compares these rules with the lighter sublingual ones.

Where Latitude operates, and who pays

Latitude's FAQ says diagnostics and visits are typically covered in-network. The one-time OIT program fee is a non-covered service whose amount Latitude does not publish; patients report roughly $4,000 in the Bay Area and over $5,000 in New York. Payment plans are offered and the fee is FSA/HSA eligible.

What Latitude publishes, and what it means

Latitude publishes outcome figures, which most clinics do not. They come from internal data, which deserves both credit and scrutiny.

of patients under 4 desensitized to their allergen(s) with OIT (internal data, 2026)
98%of patients under 4 desensitized to their allergen(s) with OIT (internal data, 2026)
of patients of all ages desensitized (internal data, 2026)
94%of patients of all ages desensitized (internal data, 2026)
of doses caused any reaction across 1,000+ OIT patients, overwhelmingly mild (AAAAI 2025, with Weill Cornell)
~5%of doses caused any reaction across 1,000+ OIT patients, overwhelmingly mild (AAAAI 2025, with Weill Cornell)
average time to maintenance, per Latitude
~8.4 moaverage time to maintenance, per Latitude

Earlier Latitude materials cited 92% desensitization within one year and 97% for under-4s, so treat the figures as a range across time and cohorts. Internal data is not peer review; ask any provider — ours included — who is in the denominator and what threshold counts as success.

Strengths and constraints, side by side

What the record supports

Latitude's real advantages, stated first.

  • Supervised escalationEvery dose increase happens under clinicians, which is exactly when reaction risk peaks. The AAAAI 2025 figure of ~5% of doses causing any reaction, mostly mild, is a strong safety record for OIT at this scale.
  • SpeedMonths, not years, to maintenance: 6–12 published, about 8.4 on average. Under direct supervision, a clinic can escalate faster than any at-home protocol responsibly can.
  • Diagnosis firstOral food challenges are the gold standard, and patients credit Latitude's challenges with removing false-positive allergy labels entirely.
  • A clean third-party recordNo BBB complaints on file, 276 strongly positive Zocdoc reviews, 8.8/10 on Atly, and no petitions or organized skepticism anywhere we could find.
  • Academic tiesAffiliations with UCSF Benioff, Weill Cornell, and CHLA, and founders linked to the Stanford Sean Parker Center world.
What families weigh against it

The constraints, equally real.

  • GeographyAbout 12 offices, all in coastal California and greater New York. The FAST directory lists OIT clinics in 35 states; 15 states plus DC have none listed at all.
  • CadenceA clinic visit at the frequent cadence OIT up-dosing requires through the active phase. In one published study, 52% of patients offered peanut OIT declined it, and the top reason, at 28.5%, was time burden.
  • The non-covered fee$4,000 to over $5,000 by patient report, on top of covered visits, for a fee Latitude discloses as non-covered without publishing the amount.
  • OIT's side-effect profileIn the head-to-head peanut trial in children, OIT produced significantly more adverse reactions and withdrawals than sublingual immunotherapy — the price of its larger, faster threshold rise.
  • Rules for lifeMaintenance dosing continues indefinitely, with rest windows, illness holds, and timing discipline attached for the duration.

Speed versus gentleness, in the post-Palforzia landscape

If the map or the math does not work

What they offer

What this provider is known for, from the public record.

  • Clinic oral immunotherapy

    Faster, larger threshold rise

    In the one head-to-head peanut trial in children, oral immunotherapy raised the reaction threshold roughly 141-fold at 12 months against roughly 22-fold for sublingual drops (with more side effects and withdrawals).

    Source: Narisety 2015, PMID 25528358

  • Latitude Food Allergy Care

    Speed to maintenance

    Latitude publishes an average of about 8.4 months of supervised active treatment to reach maintenance.

    Source: latitudefoodallergycare.com

  • Latitude Food Allergy Care

    Insurance billing and challenge-based diagnosis

    Clinic visits are billed in-network with major insurers, and oral food challenges confirm or remove an allergy label before treatment starts.

    Source: Latitude FAQ

How food allergy drops are regulated

Personalized allergy drops are compounded for each individual patient. Such formulations are not reviewed by the FDA. However, they remain common practice for allergists and ENT allergists because they provide a convenient alternative to allergy shots. Allergy drops are the standard of care in many EU countries.

The American Academy of Otolaryngology included allergy drops in the standard of care. The FDA has approved four sublingual tablets for single allergens; allergy drops are compounded, target multiple allergies at once, and remain off-label.

Has the FDA written to Curex about allergy drops? Once, in 2021: an untitled letter about how the drops were marketed. Curex changed its website, responded in April 2021, and has had no FDA correspondence about allergy drops since.

Does the 2025 FDA warning letter concern allergy drops? No. The September 2025 warning letter concerned marketing language for compounded GLP-1 weight-loss products; Curex made the requested changes.

Every letter and response: Curex and the FDA. The short version: Is Curex legit?

The practical next step

Frequently Asked Questions

If you experience sudden difficulty breathing, throat swelling, or other signs of anaphylaxis, call 911. A prescribed epinephrine auto-injector is the first-line treatment — not antihistamines.

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.

Ready to treat your allergies at the source?

Take the free allergy quiz to find out if immunotherapy is right for you and get started with personalized treatment today.

Take Free Allergy Quiz